SOD2 and Alzheimer disease: In this study, therefore, we assessed the effect of Sod2 reduction in this animal model of AD by measuring the extent of oxidative stress in both young mice at 5–7 months of age, in which amyloid deposition is not yet apparent, as well as in aged mice, at 25–30 months of age.